Improved neutralization of the SARS-CoV-2 Omicron variant after Pfizer-BioNTech BNT162b2 COVID-19 vaccine boosting
K. Basile, R. J. Rockett, K. McPhie, M. Fennell, J. Johnson-Mackinnon, J. Agius, W. Fong, H. Rahman, D. Ko, L. Donavan, L. Hueston, C. Lam, A. Arnott, S. Chen, S. Maddocks, , J. Kok
This study shows that Pfizer-BioNTech vaccine boosting increases neutralizing antibodies against Omicron, but they are still lower than against the A.2.2 lineage.
bioRxiv · Dec 12, 2021 · PreprintMicrobiology